These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19422321)

  • 1. Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?
    Agúndez JA; García-Martín E; Martínez C
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):607-20. PubMed ID: 19422321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding.
    Blanco G; Martínez C; Ladero JM; Garcia-Martin E; Taxonera C; Gamito FG; Diaz-Rubio M; Agundez JA
    Pharmacogenet Genomics; 2008 Jan; 18(1):37-43. PubMed ID: 18216720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical pharmacogenomics for CYP2C8 and CYP2C9: general concepts and application to the use of NSAIDs].
    Martínez C; Blanco G; García-Martín E; Agúndez JA
    Farm Hosp; 2006; 30(4):240-8. PubMed ID: 17022718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers.
    Ochoa D; Prieto-Pérez R; Román M; Talegón M; Rivas A; Galicia I; Abad-Santos F; Cabaleiro T
    Pharmacogenomics; 2015; 16(9):939-48. PubMed ID: 26122864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
    Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
    Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CYP2C9 genotype on pharmacokinetics: are all cyclooxygenase inhibitors the same?
    Rodrigues AD
    Drug Metab Dispos; 2005 Nov; 33(11):1567-75. PubMed ID: 16118328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use.
    Martínez C; Blanco G; Ladero JM; García-Martín E; Taxonera C; Gamito FG; Diaz-Rubio M; Agúndez JA
    Br J Pharmacol; 2004 Jan; 141(2):205-8. PubMed ID: 14707031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers.
    López-Rodríguez R; Novalbos J; Gallego-Sandín S; Román-Martínez M; Torrado J; Gisbert JP; Abad-Santos F
    Pharmacol Res; 2008 Jul; 58(1):77-84. PubMed ID: 18694831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.
    García-Martín E; Martínez C; Tabarés B; Frías J; Agúndez JA
    Clin Pharmacol Ther; 2004 Aug; 76(2):119-27. PubMed ID: 15289789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the relationship between polymorphisms in CYP2C8 and CYP2C9 and the pharmacokinetics of celecoxib.
    Prieto-Pérez R; Ochoa D; Cabaleiro T; Román M; Sánchez-Rojas SD; Talegón M; Abad-Santos F
    J Clin Pharmacol; 2013 Dec; 53(12):1261-7. PubMed ID: 23996211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding.
    Macías Y; Gómez Tabales J; García-Martín E; Agúndez JAG
    Expert Opin Drug Metab Toxicol; 2020 Apr; 16(4):319-332. PubMed ID: 32187502
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.
    Kirchheiner J; Roots I; Goldammer M; Rosenkranz B; Brockmöller J
    Clin Pharmacokinet; 2005; 44(12):1209-25. PubMed ID: 16372821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.
    Yasar U; Lundgren S; Eliasson E; Bennet A; Wiman B; de Faire U; Rane A
    Biochem Biophys Res Commun; 2002 Nov; 299(1):25-8. PubMed ID: 12435384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of CYP2C9 genetic variants on gastrointestinal bleeding associated with nonsteroidal anti-inflammatory drugs: a systematic critical review.
    Estany-Gestal A; Salgado-Barreira A; Sánchez-Diz P; Figueiras A
    Pharmacogenet Genomics; 2011 Jul; 21(7):357-64. PubMed ID: 21597400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 CYP2C9 polymorphism and NSAID-related acute gastrointestinal bleeding.
    Agúndez JA; Martínez C; García-Martín E; Ladero JM
    Gastroenterology; 2007 Dec; 133(6):2071-2; author reply 2072-3. PubMed ID: 18054585
    [No Abstract]   [Full Text] [Related]  

  • 16. How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity.
    Krasniqi V; Dimovski A; Domjanović IK; Bilić I; Božina N
    Arh Hig Rada Toksikol; 2016 Mar; 67(1):1-8. PubMed ID: 27092633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Major Involvement of Common
    Macías Y; García-Menaya JM; Martí M; Cordobés C; Jurado-Escobar R; Cornejo-García JA; Torres MJ; Blanca-López N; Canto G; Blanca M; Laguna JJ; Bartra J; Rosado A; Fernández J; García-Martín E; Agúndez JAG
    Front Pharmacol; 2021; 12():648262. PubMed ID: 34621165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers.
    Dorado P; Cavaco I; Cáceres MC; Piedade R; Ribeiro V; Llerena A
    Eur J Clin Pharmacol; 2008 Oct; 64(10):967-70. PubMed ID: 18548238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotype.
    van Dijk KN; Plat AW; van Dijk AA; Piersma-Wichers M; de Vries-Bots AM; Slomp J; de Jong-van den Berg LT; Brouwers JR
    Thromb Haemost; 2004 Jan; 91(1):95-101. PubMed ID: 14691574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.
    García-Martín E; Martínez C; Ladero JM; Agúndez JA
    Mol Diagn Ther; 2006; 10(1):29-40. PubMed ID: 16646575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.